版本:
中国

Sanofi SA (SASY.PA)

SASY.PA ( Paris Stock Exchange )

72.87EUR
18 Apr 2019
涨跌 (%)

€-0.19 (-0.26%)
收盘
€73.06
开盘
€72.50
当日最高
€73.83
当日最低
€72.50
成交量
4,515,930
平均成交量
2,341,634
52 周最高
€80.44
52 周最低
€63.25

概况

Sanofi是一家医疗保健公司。该公司专注于患者需求并从事研究、开发、制造和销售治疗方案业务。该公司的业务部门包括医药、人类疫苗(疫苗)和其他。医药业务部门从事各类特许经营业务的商业运作,包括专业护理(罕见疾病、多发性硬化症及肿瘤病),糖尿病及心血管,处方药,消费者保健及仿制药,以及该公司的药品研发、生产及销售业务。疫... (更多)

概况

Beta: 0.74
市值(百万): €90,951.52
已发行股本(百万): 1,248.14
股息: 3.07
股息收益率 (%): 4.16

财务指标

  SASY.PA Industry Sector
P/E (TTM): 21.18 62.06 62.40
EPS (TTM): 3.44 -- --
ROI: 4.41 12.17 11.78
ROE: 7.39 13.11 12.61

Boehringer's operating income flat as integration costs weigh

FRANKFURT, April 17 German drugmaker Boehringer Ingelheim reported on Wednesday flat operating income of 3.5 billion euros ($4 billion) for 2018, held back by the costs of integrating the animal medicines business it acquired from Sanofi. 全文
04/17 18:44

Sanofi to cut U.S. insulin costs for some patients to $99 per month

NEW YORK, April 10 Sanofi SA said on Wednesday it will cut the cost of its insulin products to $99 per month for uninsured patients and others who pay cash for it in the United States, as the French drugmaker contends with intense criticism over the high price of the life-sustaining diabetes medication. 全文
04/10 17:00

UPDATE 2-Regeneron forays into gene-silencing therapies with Alnylam tie-up

April 8 Regeneron Pharmaceuticals Inc said it would invest $800 million in Alnylam Pharmaceuticals Inc to develop treatments for eye and central nervous system diseases using gene-silencing RNA interference (RNAi) technology. 全文
04/08 23:13

U.S., China key to GSK's consumer venture with Pfizer

LONDON, April 4 The United States and China will be key focuses for the consumer healthcare venture being formed by GlaxoSmithKline and Pfizer, as the companies look to build on strong existing positions in those markets. 全文
04/04 22:39

MOVES-Activist hedge fund Sarissa hires president in push for growth

BOSTON, April 4 Sarissa Capital Management LP, the activist hedge fund run by Alexander Denner that invests in pharmaceutical and healthcare companies, has hired asset management veteran Eric Vincent as president, according to his LinkedIn profile and two people familiar with the matter. 全文
04/04 21:03

European shares sink as recession risk fears hit home

March 25 European shares opened deep in the red on Monday, adding to the worst weekly fall of the year last week after disappointing economic data in Europe and the United States stoked fears of recession. 全文
03/25 16:40

UPDATE 1-FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes

March 22 The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals Inc intended for use with insulin in patients with type 1 diabetes, the companies said on Friday. 全文
03/23 02:39

FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes

March 22 The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals Inc intended for use with insulin in patients with type 1 diabetes, the companies said on Friday. 全文
03/23 02:21

Amarin's Vascepa cuts occurrence of serious heart problems 30 pct -study

March 18 A high dose of Amarin Corp's Omega-3 drug Vascepa significantly reduced the occurrence of first and subsequent heart attacks, strokes and other serious heart problems in high-risk patients already taking cholesterol medication by even more than initially reported, according to data presented on Monday. 全文
03/18 21:00

UPDATE 2-BioNTech hires banks for IPO worth up to $800 million -sources

* IPO eyed in Q4 or early 2020-sources (Adds BioNTech comment) 全文
03/13 04:28

收益 vs. 预测